New recommendations for managing adult AMLJanuary 30, 2017Leukemia, Myelodysplasia, TransplantationAML
Study quantifies 5-year survival rates for blood cancersJanuary 25, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Bank could help docs identify optimal AML treatment, team saysJanuary 17, 2017Leukemia, Myelodysplasia, TransplantationAML
Predicting response to cytarabine in AML patientsJanuary 12, 2017Leukemia, Myelodysplasia, TransplantationAML
Infection in AML patient prompts discoveryJanuary 4, 2017Leukemia, Myelodysplasia, TransplantationPediatricsRelated IssuesAML
Drugs may be effective against hematologic, other cancersJanuary 2, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLCMLAggressive Lymphomas
FDA places AML trials on full, partial clinical holdDecember 28, 2016Leukemia, Myelodysplasia, TransplantationAML
Intermittent fasting fights ALL, not AML, in miceDecember 21, 2016Leukemia, Myelodysplasia, TransplantationAMLALL
Predicting therapy-related myeloid neoplasmsDecember 13, 2016AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLMyelodysplastic Syndrome
Agent exhibits activity in relapsed/refractory AMLDecember 10, 2016Leukemia, Myelodysplasia, TransplantationAML
Group estimates global cancer cases, deaths in 2015December 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesAMLALLHodgkin Lymphoma
Combo shows early promise in newly diagnosed AMLDecember 6, 2016Leukemia, Myelodysplasia, TransplantationAML